DatasetName,PARP1_S(364) PARP1_S(785),PARP1_S(167) PARP1_S(177) PARP1_S(179) PARP1_S(185) PARP1_S(204) PARP1_S(257) PARP1_S(274) PARP1_S(277) PARP1_S(352) PARP1_S(368) PARP1_S(41) PARP1_S(463) PARP1_S(479) PARP1_S(542) PARP1_S(75) PARP1_S(782) PARP1_S(786) PARP1_S(808) PARP1_T(189) PARP1_T(355) PARP1_T(368) PARP1_T(393) PARP1_T(420) PARP1_T(6)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,0.48839629249790684
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,0.4754710780254989
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,0.4709677792409251
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.48494102891340113
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.4850318881001337
RKK2015_TNF-α/basal,,0.4949510238161015
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.47838606949294243
HS2024_6_B_T3,,0.4842922921759088
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,0.47882515064163605
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,0.4910829578742499
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,0.4824081973767336
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,0.482948297929971
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.4879187633321486
WZ2023_Pu_010_30min,0.6288709250161482,0.4877795914247476
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.48749128479354825
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.47672580173232043
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,0.4887007512045294
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,0.4838547661527966
AH2018_SILAC_MR_2_N,,0.49043155285651285
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,0.49061482584780053
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.47302387538100543
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,0.48425081743146653
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.4877609089529398
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,0.4903691024872505
RB2022_5_PostStrength,,
GF2025_P6_Sph,,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.47892218126028446
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.6482004377425228,0.491024843402327
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.6559852157638794,0.491746977310558
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.4840635128841439
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.6581677904218582,0.4888947310488556
AH2018_SILAC_MR_2_X,,0.48510545347893763
HS2024_4_PD_T2,,0.4928563210166002
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.48663468679160427
FR2021_Norm.Intensity.B,,0.48194637404049384
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,0.48950311268934765
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,0.48838180799503433
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.48577272716739084
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.48626202665708257
HS2024_7_PD_T2,,0.4814793606013284
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,0.4854854644398368
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6521552202376962,0.4900850051485575
CK2022_11 40-1,,0.4835712198406547
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.48460457158484704
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.48777032769342393
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.6392509414984113,0.48859518703266724
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.48583639503433673
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,0.4812233083287456
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.4852171403508568
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,0.479091352150881
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,0.48687226523239463
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,0.4872058197345525
FR2021_Norm.Intensity.H,,0.48324477448432995
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,0.482359137807796
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.48253429539578657
CK2022_1 200-1,,0.48737744910749187
PG2020_Intensity Mock_10h_D,,0.4760526847969336
SR2019_MCF10A_Biol_repl_2,,0.48198205722722715
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,0.488981240007152
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.5020959997037105
RCJD2014_5min_1,,0.4852781434014466
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,0.4865483601130802
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,0.4904330281500258
SAS2015_PLX/AZD_Exp2,,0.49530866315251615
CR2017_Ratio Replicate 3.3,,0.48712887584651204
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.4786299339129647
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,0.49456673130332574
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,0.47985417058756713
HS2024_5_PD_T1,,0.4857356509840138
AH2018_LFQ_M_2_C,,0.4867892203727317
CK2022_3 40-1,,0.48488068295629216
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,0.48471751362099763
YA2020_Reporter_intensity_Cancer_No.5,,0.4870348628953311
HH2022_Reporter intensity 8,,
ZQ2022_N2,,0.48258960382511074
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.48647716010026265
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,0.4830442689021502
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.4868651367023005
YA2020_Reporter_intensity_Normal_No.1,,0.48585431677775603
HS2024_3_B_T1,,0.48621985065753087
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.4857037535412763
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,,0.4747323792339819
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,0.4922881480423817
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.6364167628664469,0.4894877887745592
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.4845209747613495
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.48511205005344826
KS2014_Intensity N3,,0.4982029316656402
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.4862583126724225
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,,0.49575067438335824
HS2024_8_PD_T1,,0.48124164144208487
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,,0.48608601751351516
BS2014_Log2(Ratio H/L protein),,0.48094510555696823
PG2020_Intensity 8h_A,,0.4834668787622394
HS2024_7_I_T1,,0.4830159684398372
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,0.483296441840517
SR2019_JIMT1_Biol_repl_1,,0.48640065636326374
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,0.4842004203050983
AH2018_SILAC_M_3_X,,0.48595933119364926
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.48904331478939955
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.4885516858470977
HS2024_6_B_N1,,0.48960578046681835
KBE2022_Log2_Ex_27_T,,0.48937744910582665
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.48555792004325804
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,0.4843026280101331
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.48029794607326437
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.4852099772975178
SR2019_HCC1954_Biol_repl_2,,0.48336443816281016
CK2022_14 40-1,,0.4846241930954658
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.47186667532289167
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,,0.48970076767984283
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.4856263217580404
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,,0.4891832181678622
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.4847478393364129
JW2021_After_3,,
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.4860494437139327
CK2022_11 200-1,,0.486551576781819
CK2022_12 200-1,,0.4875057249339199
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,0.4809953158938407
WZ2023_Su_010_20min,0.6339905697817765,0.4890950037210033
AH2018_TMTMS2_2_N,,0.47944098234423205
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.48627279981618776
AH2018_TMTMS3_Pool,,0.49090880580928803
KS2014_Intensity N4,,0.5005572676336182
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,,0.48912423491804596
SR2019_Hs578T_Biol_repl_1,,0.4844735085011085
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,0.49025037617215766
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.4873388237996963
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,0.4812751462267231
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.4837798948391163
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,0.48885092009843706
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.639878838731677,0.49137421705116924
CF2017_EOC 1,,
CK2022_3 200-1,,0.4869137594601774
AH2018_LFQ_IT_3_C,,0.48281781730429324
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,0.48421284287319916
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,0.4784114490005548
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,0.4843879635968316
HS2024_5_B_T1,,0.47903198228561705
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,0.48497306505735976
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.4847493521837641
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.4876029407388063
JW2021_Before_2,,
TM2022_S2.12h.A,,0.4905838795661801
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.48488550347774284
AR2021_ALG 1 μM,,
HS2024_4_B_T1,,0.4847831956868028
MV2014_Ratio M/H normalized A3___1 (10 min),,0.48463221490079067
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,0.49302580116257283
CR2017_Ratio Replicate 3.2,,0.4883135382762261
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,,0.4833416263333758
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.4890227113745618
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,,0.4845729224358966
FS2019_db/db3,,
CK2022_15 40-1,,0.4844401522827296
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.6284636221079996,0.48879566611778075
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.484600595678643
HS2024_5_PD_T3,,0.4898378568884432
AH2018_TMTMS3_3_X,,0.4856649817523416
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,,0.48888385429314707
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,0.48075610678528974
AH2018_SILAC_M_1_N,,0.48639764408793873
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,0.4863113940097837
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.48220806595970994
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,0.4888948058367426
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,0.4839730597691814
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,0.4876664043269594
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.48433020337874355
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.4927978966873295
HH2022_Reporter intensity 6,,0.48158701338602555
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.47884973655636115
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.48068971099467195
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,0.48763523305757706
AH2018_TMTMS2_1_C,,0.47338036050577476
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.48314262423932686
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.48334934118134454
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,0.48647842506953026
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,0.4914713608745711
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,0.48586573957645807
HS2024_8_B_T2,,0.4830452109941419
AH2018_LFQ_1_X,,0.48635135181306355
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,0.4788715894648325
FR2021_Norm.Intensity.M,,0.48381483040803364
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.5002366939790186
HH2022_Reporter intensity 1,,0.48954427467168743
HH2022_Reporter intensity 2,,0.48960525807962196
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.48623746173465926
SR2019_MCF7_Biol_repl_1,,0.48998006935448307
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,0.4860111624439818
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.5024583477826551
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.4867357290194352
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,,0.480814475610768
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.4903607559620682
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.4876211341591325
KBE2022_Log2_Ex_9_U,,0.48492293604112136
AH2018_SILAC_M_3_N,,0.4869853331255287
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,0.48701055222973505
PG2020_Intensity Mock_10h_C,,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,0.4850988895326382
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.484365543177573
SAS2015_PLX/AZD_Exp1,,0.4842317003227263
FR2021_Norm.Intensity.A,,0.4831888390585844
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.4850549812245147
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,0.49067339136597155
RN2012_L15,,0.4856857298150177
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,0.49007473085949754
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,0.49068553698238526
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.4879594825318618
RB2022_1_PreSprint,,
HS2024_4_I_N1,,0.48285093015838654
CK2022_7 200-1,,0.4901326243958963
CK2022_5 200-1,,0.48776555027794316
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,0.48561728713363234
AH2018_SILAC_MR_1_X,,0.4831612074785347
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,0.47872312709537695
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,,0.4843681430336752
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,,0.4828539879320182
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,0.4875371260502617
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,0.4887746254828332
SFR2015_HL_log2_ratio_avg_c,,0.48673792227012425
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,0.4832077550418232
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,0.4859158292920743
KBE2022_Log2_Ex_9_T,,0.4880210322818365
AH2018_SILAC_IT_2_N,,0.484729861429311
AH2018_SILAC_IT_1_X,,0.4815324054818145
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,0.4824677176385362
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,0.6648493470350983,0.4919190821784094
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.4872970225011744
HS2024_4_I_N2,,0.4831895712696923
AH2018_TMTMS2_3_N,,0.47294462967387313
RN2012_H06,,0.48634467241042606
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,0.48531152008147194
WZ2023_Su_005_30min,0.6414696422445558,0.48712228594440093
SR2019_HCC1419_Biol_repl_4,,0.48873781506650776
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,0.48754575938652084
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.4845419969758337
WZ2023_Su_025_10min,0.6482879951337717,0.49100392644686575
AH2018_LFQ_IT_4_X,,0.48577077622981574
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.6385154535641031,0.4879798929733337
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,0.4859937730690311
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,0.48335155186845563
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,0.49339537313253334
MV2014_Ratio H/M normalized A2___1 (2 min),,0.4853012374656866
PG2020_Intensity 8h_D,,0.4846832349854105
LY2019_P7+,,0.4904642548009941
EP2017_Untreated R#1 normalized log2 ratio,,0.47846592401945376
RN2012_L10,,0.4781039664074218
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,,0.5005777216672951
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,0.48304927298718064
HS2024_4_B_T3,,0.4798752875845697
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,0.4908899204046777
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,0.4895364536145122
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.48332587733278265
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.48924744795847536
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.5026948814511781
GF2025_P9_Sph,,
CK2022_6 200-1,,0.4877196240050315
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.48439169666887705
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,0.48366782110422424
HS2024_4_I_T2,,0.48702059402897113
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,0.4837944300181949
SAS2015_AZD/DMSO_Exp1,,0.49349365625026836
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,0.5002068033594572
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,,0.49608695671983155
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.4895412229267491
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.4895392310117028
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,0.49113464406721946
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.49092544075997985
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.4828109674927658
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,0.48565173303714665
KBE2022_Log2_Ex_29_T,,0.48671071463759397
HS2024_7_I_T2,,0.48275709232297764
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,0.48917975510220724
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,0.5015596261175075
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,0.48381483040803364
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.49048365964600243
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,,0.48300818468036094
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,,0.49691120503886266
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.4903737309042613
HS2024_8_PD_T2,,0.48143686533941343
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,0.4821714504880372
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,0.48626512455201354
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,0.4732518098211845
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,0.4914556509386537
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,0.4873946009634557
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,0.49009482200759386
HS2024_3_PD_T3,,0.48658755317733743
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,0.48275878373435993
RAM2015_Log2 C,,0.4910972618287934
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.4883657425820034
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,0.48202403782851994
RAM2015_Log2 B,,0.4848778140490157
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,0.4871765521712663
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,0.4847655096354604
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,0.6420230197730354,0.490009486397694
AH2018_LFQ_4_N,,0.4894114826090623
CR2017_Ratio Replicate 1.2,,0.48411393098554845
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,0.49557097811913664
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,0.4860630942853162
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.5017367532467975
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,0.4919658755623522
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.48565771101383365
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,0.48666217015150354
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,0.49061860634827076
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,0.47733027310086534
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.49034809873853474
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.48295542887298876
AH2018_LFQ_2_X,,0.4872218134721184
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,0.4867781106012847
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,0.4864501533363679
AH2018_SILAC_1_C,,0.48503190787220957
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.4877182082816287
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.4835144316067153
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.4896644914954684
ZQ2022_N1,,0.4853491845674671
LY2019_P6-,,0.49183114212131424
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.48739388152619595
AH2018_LFQ_3_N,,0.48712887821543815
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,0.5000905724610643
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.4855187070334949
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,0.49319987754769684
WZ2023_Su_025_20min,0.6417597514841334,0.48847991866650103
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.48856159186401427
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.48464991854233447
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,0.4742947513759854
PG2020_Intensity 10h_D,,0.4784839279254325
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,0.48789205408972025
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,,0.48775866071282176
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,0.47800163947297586
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.48448463593476676
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,0.4853236621141434
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,0.48922871289291064
FR2021_Intensity.A,,0.48257553392717956
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.635977007514245,0.4908710719303034
HS2024_8_PD_T3,,0.4860784207549975
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.6382097397158344,0.48926589209751303
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,0.48397887122890854
FR2021_Norm.Intensity.N,,0.48354332666115707
HS2024_5_B_N1,,0.48997374413222644
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.476238535143156
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.4869075673031627
HS2024_8_I_N2,,0.48548221797291674
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.4856138204059997
LY2019_P8+,,0.48789612697639684
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,0.48583987078799934
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.4858057372886056
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.49003853079688936
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,,0.49529284363535936
AH2018_LFQ_IT_1_X,,0.48590828467343167
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.6361897164435371,0.48938600969211493
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,0.4862241676588582
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,0.4743818817814341
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.48475792128501755
SR2019_MCF10A_Biol_repl_4,,0.4903431453083562
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,,0.4796918069508649
HS2024_6_I_T1,,0.48155507433583616
HS2024_5_B_T3,,0.47924033666095595
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.4873664459331231
AH2018_TMTMS3_3_N,,0.48653249344906385
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,0.48353514843737333
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.4847823661239227
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,0.5029261233087088
KBE2022_Log2_Ex_36_T,,0.48725102440257634
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6447426918288923,0.4891929750813502
KS2014_Intensity C2,,0.4866114225864488
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,,0.48671436819902514
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.48739339619958993
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,0.4840860865505716
RBK2021_1332T Late,,
LY2019_P1-,,0.4829548961379588
RKK2015_TNF-α/basal.1,,0.4859678154696257
RKK2015_TNF-α/TNF-α+SC-514,,0.48861059066160917
CR2017_Ratio Replicate 2.5,,0.49131944280030687
HS2024_3_I_T3,,0.4841759191689417
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.4844400408497594
ZQ2022_C3,,0.4906925220006056
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.47902848794279196
RKK2015_SC-514/basal,,0.5070175117672985
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.6296882286669925,0.4884270422771413
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,0.4893057098268183
HS2024_5_I_T3,,0.47853566289613486
KS2014_Intensity N1,,0.5000677763513909
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,0.4906303637100557
CR2017_Ratio Replicate 1,,0.4856297023718939
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.4847039125233608
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.4858513939686899
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,0.4887700218481091
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,0.48815933729631483
HS2024_5_I_N1,,0.4838732381117347
HS2024_6_I_N1,,0.4889833820033758
AR2021_KD 48h,,0.4848211680716277
FR2021_Intensity.B,,0.48193283584005425
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,0.4834504854611877
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.6431983417390523,0.48859555389959847
KBE2022_Log2_Ex_29_U,,0.4866886910195978
HS2024_7_B_T1,,0.49365020206614707
AH2018_LFQ_M_2_X,,0.48841528707017906
AH2018_LFQ_IT_4_N,,0.4868620858376221
CK2022_15 200-1,,0.48914480285273526
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.48445185981334543
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.48792465445765987
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6441227702634837,0.4880553891027866
RN2012_H01,,0.4974672699316873
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.48342571249543714
HS2024_8_B_T3,,0.48645440075443536
YA2020_Reporter_intensity_Cancer_No.3,,0.4868968924759777
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.6433256245810159,0.4889340206591774
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,0.48804885560371797
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,0.484224702960855
KS2014_Intensity C1,,0.4851177301173946
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,,0.484591002744346
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.48310959866459596
AH2018_SILAC_M_2_X,,0.4844363275529082
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.6433335360428782,0.4888266700250299
PG2020_Intensity 6h_C,,0.48088314978770397
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.4882063811685516
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.4754155919643392
CK2022_15 16-1,,0.48415465308915745
CK2022_3 16-1,,0.48367684904700486
LY2019_P4-,,0.48873827280382126
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,0.4860038568081466
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,,0.48302967920106776
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.4870191408230526
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,0.4985983167969796
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.5048337713560945
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,,0.48631900218433793
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.4862649679799549
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,0.48505274660470193
CK2022_6 16-1,,0.484315906230053
ZX2022_CB treated Replicate 1,,0.47853109063920646
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,0.49079661124192914
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,0.48919827125727006
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.47687771159988074
AR2021_L41 1 μM,,0.4895873609465118
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.48036870990130826
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.4787551930041805
KS2014_Intensity C4,,0.4865305745520458
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.48520900564995856
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,0.48519179321431993
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,0.48784533168730365
SAS2015_PLX/DMSO_Exp3,,0.49017298132816056
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.4856066928974337
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.48625608137093373
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,0.4855087830639362
WZ2023_Pu_025_10min,0.6484888008172411,0.4925701156514926
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,0.49444366385196625
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,0.48751343462716806
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,0.47812069169114996
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.6456823551515015,0.4898594777473629
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.4860334604167513
KS2014_Intensity C6,,0.4813805563699229
ZQ2022_N3,,0.4850705947930238
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.4836995078458601
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.4788583359609644
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.48459818825732254
AH2018_SILAC_IT_2_C,,0.4852268105812893
CK2022_5 40-1,,0.4852998944005913
AH2018_LFQ_3_X,,0.48629985925984687
UK2020_UA_3,,
LY2019_P7-,,0.4902524424173161
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,0.48568231303255566
CR2017_Ratio Replicate 2.2,,0.4904790382173218
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,0.47974648660637303
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.48175883694962857
ZQ2022_C1,,0.4914083709471495
CR2017_Ratio Replicate 2.1,,0.49146155043943046
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.48847390793706874
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,0.49428853841300374
AH2018_LFQ_3_C,,0.4841247589029845
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.4874448649228924
YA2020_Reporter_intensity_Cancer_No.4,,0.4855625943871149
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,0.48324477448432995
CK2022_14 16-1,,0.48295680380632433
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,0.4865717455444764
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,0.5041805007449068
AH2018_TMTMS2_1_X,,0.47559456812964696
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,0.4910599810827813
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,0.48383392293875316
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,0.49059917751306675
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,0.4884969369878363
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,,0.4968588583902933
AH2018_SILAC_1_X,,0.485913941423628
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,,0.4857245066786949
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.47799295391094687
SR2019_HCC1419_Biol_repl_3,,0.48912426828783445
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,,0.5015916213619525
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.4750449489429939
HS2024_5_I_N2,,0.4962408073197003
SAS2015_PLX/AZD_Exp3,,0.4906124657330657
EP2017_Pervanadate R#2 log2 ratio,,0.490888508976247
AS2011_Ratio H/L Normalized RNAi_2_1,,
